Cover Image
Market Research Report

Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023

Published by MarketsandMarkets Product code 318506
Published Content info 145 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
Published: February 12, 2019 Content info: 145 Pages
Description

The pen needles market is projected to grow at a CAGR of 11% during the forecast period.

The pen needles market is expected to reach 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period. Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market. On the other hand, the preference for alternative modes of drug delivery and the poor reimbursement scenario in developing countries are key factors restricting market growth to a certain extent. The reuse of pen needles is another key factor challenging market growth.

By type, the safety pen needles segment is expected to grow at the highest rate during the forecast period.

On the basis of type, the pen needles market is segmented into standard and safety pen needles. The safety pen needles segment is expected to grow at the highest CAGR during the forecast period as they reduce direct pressure on the skin due to their wide shield diameter.

The retail segment dominated the market in 2018.

On the basis of mode of purchase, the pen needles market is segmented into retail and non-retail. The retail segment dominated the market in 2018. This can be attributed to the significant discounts offered on the online/retail purchases of pen needles and the convenience associated with online purchases.

The Asia Pacific pen needles market is expected to grow at the highest CAGR during the forecast period.

Asia Pacific, comprising China, India, Japan, and Rest of Asia Pacific countries offers high-growth opportunities for players in the pen needles market. This segment is slated to register the highest CAGR during the forecast period. Some of the factors driving market growth in the Asia Pacific region are high patient population, rising healthcare expenditure, and increasing healthcare access.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 2-25% and Tier 3-20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - North America-38%, Europe-23%, Asia Pacific-29%, RoW-10%

The key players in the pen needles market are: Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford.

Research Coverage:

The report analyzes the pen needles market and aims at estimating the market size and future growth potential of this market based on various segments such as type, length, therapy, mode of purchase, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the services offered by the top players in the pen needles market. The report analyzes the market based on type, length, therapy, mode of purchase, and region
  • Product Development/Innovation: Detailed insights on new product launches in the pen needles market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various pen needles across regions
  • Market Diversification: Exhaustive information about solutions and services, untapped regions, recent developments, and investments in the pen needles market
  • Competitive Assessment: In-depth assessment of market shares, strategies, distribution networks, and manufacturing capabilities of the leading players in the market
Table of Contents
Product Code: MD 2851

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PEN NEEDLES MARKET OVERVIEW
  • 4.2. EUROPE: PEN NEEDLES MARKET, BY TYPE & COUNTRY, 2018
  • 4.3. NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2018
  • 4.4. PEN NEEDLES MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing prevalence of chronic diseases
      • 5.2.1.2. Favorable reimbursement in selected countries
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Preference for alternative modes of drug delivery
      • 5.2.2.2. Poor reimbursement scenario in developing countries
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing preference for biosimilar drugs
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Reuse of pen needles

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. PORTER'S FIVE FORCES ANALYSIS
    • 6.2.1. THREAT OF NEW ENTRANTS
    • 6.2.2. BARGAINING POWER OF SUPPLIERS
    • 6.2.3. BARGAINING POWER OF BUYERS
    • 6.2.4. SEGMENT RIVALRY
    • 6.2.5. THREAT OF SUBSTITUTES
  • 6.3. COMPETITIVE INTENSITY
    • 6.3.1. EVALUATION PARAMETERS
    • 6.3.2. SCORING METHODOLOGY
    • 6.3.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 6.3.3.1. Competitive intensity score for BD
      • 6.3.3.2. Competitive intensity score for Novo Nordisk
      • 6.3.3.3. Competitive intensity score for Ypsomed
    • 6.3.4. COMPETITIVE INTENSITY MAPPING OF BD, NOVO NORDISK, AND YPSOMED
    • 6.3.5. COMPARISON OF EVALUATION PARAMETERS, BY COMPANY
      • 6.3.5.1. Pricing
      • 6.3.5.2. Product portfolio
      • 6.3.5.3. Product launches/technological advancements
      • 6.3.5.4. Geographical presence
      • 6.3.5.5. Promotional/marketing activities
      • 6.3.5.6. Sponsorships/Donations/Education/Awareness Campaigns
      • 6.3.5.7. M&A, Partnerships, Collaborations, Agreements, and Expansions
      • 6.3.5.8. Certifications/Accreditations/Awards

7. PEN NEEDLES MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. STANDARD PEN NEEDLES
    • 7.2.1. STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE, CONSIDERING THE NEED FOR DAILY INSULIN INTAKE
  • 7.3. SAFETY PEN NEEDLES
    • 7.3.1. DEMAND FOR SAFETY PEN NEEDLES TO RISE DUE TO GROWING CONCERNS REGARDING THE PREVENTION OF NSIS ASSOCIATED WITH STANDARD NEEDLES

8. PEN NEEDLES MARKET, BY LENGTH

  • 8.1. INTRODUCTION
  • 8.2. 4MM
    • 8.2.1. 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 8.3. 5MM
    • 8.3.1. 5MM PEN NEEDLES TO REGISTER THE SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD
  • 8.4. 6MM
    • 8.4.1. 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE
  • 8.5. 8MM
    • 8.5.1. 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
  • 8.6. 10MM
    • 8.6.1. AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET
  • 8.7. 12MM
    • 8.7.1. POPULARITY OF SHORTER & LESS PAINFUL NEEDLES TO HAMPER THE GROWTH OF THE 12MM PEN NEEDLES MARKET

9. PEN NEEDLES MARKET, BY THERAPY

  • 9.1. INTRODUCTION
  • 9.2. INSULIN THERAPY
    • 9.2.1. RISING PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY
  • 9.3. GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY
    • 9.3.1. STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS IN THE MARKET TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET FOR GLP-1. THERAPY
  • 9.4. GROWTH HORMONE THERAPY
    • 9.4.1. DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY
  • 9.5. OTHER THERAPIES

10. PEN NEEDLES MARKET, BY MODE OF PURCHASE

  • 10.1. INTRODUCTION
  • 10.2. RETAIL
    • 10.2.1. RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES
  • 10.3. NON-RETAIL
    • 10.3.1. THE LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT

11. PEN NEEDLES MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. EUROPE
    • 11.2.1. GERMANY
      • 11.2.1.1. High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany
    • 11.2.2. UK
      • 11.2.2.1. NHS support and access to cost-effective pen needles are likely to drive the market in the UK
    • 11.2.3. FRANCE
      • 11.2.3.1. Higher insurance coverage and increase in aging population and affordability contribute to demand for pen needles
    • 11.2.4. ITALY
      • 11.2.4.1. Wide regional variations in terms of benefits and coverage to slow growth in Italy
    • 11.2.5. SPAIN
      • 11.2.5.1. Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market
    • 11.2.6. REST OF EUROPE
  • 11.3. NORTH AMERICA
    • 11.3.1. US
      • 11.3.1.1. US dominates the pen needles market in North America
    • 11.3.2. CANADA
      • 11.3.2.1. High diabetes prevalence and growing geriatric population will support pen needle uptake
  • 11.4. ASIA PACIFIC
    • 11.4.1. JAPAN
      • 11.4.1.1. High diabetes incidence and approval of injectable insulin to drive the pen needles market in Japan
    • 11.4.2. CHINA
      • 11.4.2.1. Suboptimal insurance coverage policies will dampen market growth
    • 11.4.3. INDIA
      • 11.4.3.1. Low pen needle penetration, lack of awareness to restrain market growth in India
    • 11.4.4. REST OF ASIA PACIFIC
  • 11.5. REST OF THE WORLD
    • 11.5.1. LATIN AMERICA
      • 11.5.1.1. Healthcare reforms to drive growth in Mexico
    • 11.5.2. MIDDLE EAST & AFRICA
      • 11.5.2.1. Favorable reforms in South Africa to bolster market growth

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE (AS OF 2017)
    • 12.2.1. BECTON, DICKINSON AND COMPANY
    • 12.2.2. NOVO NORDISK
    • 12.2.3. YPSOMED
  • 12.3. COMPETITIVE LEADERSHIP MAPPING (2017)
    • 12.3.1. VENDOR INCLUSION CRITERIA
    • 12.3.2. VISIONARY LEADERS
    • 12.3.3. INNOVATORS
    • 12.3.4. DYNAMIC DIFFERENTIATORS
    • 12.3.5. EMERGING COMPANIES
  • 12.4. COMPETITIVE SCENARIO
    • 12.4.1. PRODUCT LAUNCHES
    • 12.4.2. EXPANSIONS
    • 12.4.3. AGREEMENTS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. BECTON, DICKINSON AND COMPANY
  • 13.2. NOVO NORDISK
  • 13.3. YPSOMED
  • 13.4. OWEN MUMFORD, LTD.
  • 13.5. HTL-STREFA
  • 13.6. B. BRAUN MELSUNGEN
  • 13.7. TERUMO CORPORATION
  • 13.8. ULTIMED
  • 13.9. ALLISON MEDICAL, INC.
  • 13.10. ARTSANA S.P.A.
  • 13.11. ARKRAY, INC.
  • 13.12. GLUCORX

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. RELATED REPORTS
  • 14.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EVALUATION PARAMETERS & SCORES
  • TABLE 2: COMPETITIVE INTENSITY FOR BD
  • TABLE 3: COMPETITIVE INTENSITY FOR NOVO NORDISK
  • TABLE 4: COMPETITIVE INTENSITY FOR YPSOMED
  • TABLE 5: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 6: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 7: STANDARD PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 8: STANDARD PEN NEEDLES MARKET, BY REGION, 2016-2023 (MILLION UNITS)
  • TABLE 9: SAFETY PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 10: SAFETY PEN NEEDLES MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 11: PEN NEEDLES MARKET, BY LENGTH, 2016-2023 (USD MILLION)
  • TABLE 12: 4MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 13: 5MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 14: 6MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: 8MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 16: 10MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 17: 12MM PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 18: PEN NEEDLES MARKET, BY THERAPY, 2016-2023 (USD MILLION)
  • TABLE 19: PEN NEEDLES MARKET FOR INSULIN THERAPY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 21: PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 22: PEN NEEDLES MARKET FOR OTHER THERAPIES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 23: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016-2023 (USD MILLION)
  • TABLE 24: PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: INDICATIVE LIST OF REGULATORY ACTS
  • TABLE 26: PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 27: PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 28: PEN NEEDLES MARKET, BY REGION, 2016-2023 (MILLION UNITS)
  • TABLE 29: EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (MILLION UNITS)
  • TABLE 31: EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 33: EUROPE: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016-2023 (USD MILLION)
  • TABLE 34: EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2016-2023 (USD MILLION)
  • TABLE 35: EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016-2023 (USD MILLION)
  • TABLE 36: GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 37: GERMANY: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 38: UK: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: UK: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 40: FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 41: FRANCE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 42: ITALY: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: ITALY: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 44: SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 45: SPAIN: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 46: ROE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 47: ROE: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 48: NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (MILLION UNITS)
  • TABLE 50: NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 51: NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 52: NORTH AMERICA: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY, 2016-2023 (USD MILLION)
  • TABLE 54: NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016-2023 (USD MILLION)
  • TABLE 55: US: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: US: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 57: CANADA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: CANADA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 59: ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: ASIA PACIFIC: PEN NEEDLES MARKET, BY COUNTRY, 2016-2023 (MILLION UNITS)
  • TABLE 61: ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: ASIA PACIFIC: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 63: ASIA PACIFIC: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016-2023 (USD MILLION)
  • TABLE 64: ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY, 2016-2023 (USD MILLION)
  • TABLE 65: ASIA PACIFIC: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016-2023 (USD MILLION)
  • TABLE 66: JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 67: JAPAN: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 68: CHINA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: CHINA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 70: INDIA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: INDIA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (MILLION UNITS)
  • TABLE 72: ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (THOUSAND UNITS)
  • TABLE 74: ROW: PEN NEEDLES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 75: ROW: PEN NEEDLES MARKET, BY REGION, 2016-2023 (MILLION UNITS)
  • TABLE 76: ROW: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: ROW: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (THOUSAND UNITS)
  • TABLE 78: ROW: PEN NEEDLES MARKET, BY NEEDLE LENGTH, 2016-2023 (USD MILLION)
  • TABLE 79: ROW: PEN NEEDLES MARKET, BY THERAPY, 2016-2023 (USD MILLION)
  • TABLE 80: ROW: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2016-2023 (USD MILLION)
  • TABLE 81: LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 82: LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (THOUSAND UNITS)
  • TABLE 83: MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: MIDDLE EAST & AFRICA: PEN NEEDLES MARKET, BY TYPE, 2016-2023 (THOUSAND UNITS)
  • TABLE 85: PRODUCT LAUNCHES
  • TABLE 86: EXPANSIONS
  • TABLE 87: AGREEMENTS

LIST OF FIGURES

  • FIGURE 1: PEN NEEDLES MARKET SEGMENTATION
  • FIGURE 2: PEN NEEDLES MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: RESEARCH DESIGN
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: PEN NEEDLES MARKET, BY TYPE, 2018
  • FIGURE 9: PEN NEEDLES MARKET, BY LENGTH, 2018-2023
  • FIGURE 10: PEN NEEDLES MARKET, BY THERAPY, 2018-2023
  • FIGURE 11: PEN NEEDLES MARKET, BY MODE OF PURCHASE, 2018
  • FIGURE 12: GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET, 2018
  • FIGURE 13: GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET
  • FIGURE 14: STANDARD PEN NEEDLES TO DOMINATE THE EUROPEAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: STANDARD PEN NEEDLES TO DOMINATE THE NORTH AMERICAN PEN NEEDLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 16: ASIA PACIFIC IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 17: PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 18: PORTER'S FIVE FORCES ANALYSIS: PEN NEEDLES MARKET
  • FIGURE 19: SCORING METHODOLOGY
  • FIGURE 20: COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK, AND YPSOMED
  • FIGURE 21: RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS
  • FIGURE 22: SAFETY PEN NEEDLES BY BD AND STANDARD PEN NEEDLES BY NOVO NORDISK ARE PREMIUM-PRICED
  • FIGURE 23: BD HAS A ROBUST PORTFOLIO OF BOTH STANDARD AND SAFETY PEN NEEDLES
  • FIGURE 24: BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS
  • FIGURE 25: BD AND NOVO NORDISK HAVE A STRONG GEOGRAPHIC PRESENCE
  • FIGURE 26: BD AND NOVO NORDISK SHOWCASE HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES
  • FIGURE 27: NOVO NORDISK HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS
  • FIGURE 28: NOVO NORDISK AGGRESSIVELY FOLLOWS THE STRATEGIES OF PARTNERSHIPS & AGREEMENTS
  • FIGURE 29: BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS
  • FIGURE 30: STANDARD PEN NEEDLES TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 31: 8MM PEN NEEDLES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018
  • FIGURE 32: INSULIN THERAPY SEGMENT TO COMMAND THE LARGEST SHARE OF THE PEN NEEDLES MARKET IN 2018
  • FIGURE 33: RETAIL SEGMENT WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD
  • FIGURE 34: EUROPE TO COMMAND THE LARGEST SHARE OF THE GLOBAL PEN NEEDLES MARKET IN 2018
  • FIGURE 35: EUROPE: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 36: NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 37: ASIA PACIFIC: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 38: REST OF WORLD: PEN NEEDLES MARKET SNAPSHOT
  • FIGURE 39: PEN NEEDLES MARKET SHARE (AS OF 2017)
  • FIGURE 40: MNM DIVE-VENDOR COMPARISON MATRIX: PEN NEEDLES MARKET
  • FIGURE 41: STRATEGIES ADOPTED BY MARKET PLAYERS (2015-2018)
  • FIGURE 42: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 43: NOVO NORDISK: COMPANY SNAPSHOT
  • FIGURE 44: YPSOMED: COMPANY SNAPSHOT
  • FIGURE 45: B.BRAUN: COMPANY SNAPSHOT
  • FIGURE 46: TERUMO: COMPANY SNAPSHOT
Back to Top